Creatine kinase: structure-activity relationships.
Kenyon GL, Reed GH.
Adv Enzymol Relat Areas Mol Biol. 1983;54:367-426. doi: 10.1002/9780470122990.ch6.
Depletion of creatine phosphagen energetics with a covalent creatine kinase inhibitor.
Darabedian N, Ji W, Fan M, Lin S, Seo HS, Vinogradova EV, Yaron TM, Mills EL, Xiao H, Senkane K, Huntsman EM, Johnson JL, Che J, Cantley LC, Cravatt BF, Dhe-Paganon S, Stegmaier K, Zhang T, Gray NS, Chouchani ET.
Nat Chem Biol. 2023 Jul;19(7):815-824. doi: 10.1038/s41589-023-01273-x. Epub 2023 Feb 23.
Creatine kinase in the dog: a review.
Aktas M, Auguste D, Lefebvre HP, Toutain PL, Braun JP.
Vet Res Commun. 1993;17(5):353-69. doi: 10.1007/BF01839386.
Creatine kinase release after catheter-based coronary intervention.
Lim R, Zawacki K, Laskey WK.
Cathet Cardiovasc Diagn. 1997 Jun;41(2):117-9. doi: 10.1002/(sici)1097-0304(199706)41:2<117::aid-ccd1>3.0.co;2-a.
Elevated creatine kinase and malignancy.
Eng C, Skolnick AE, Come SE.
Hosp Pract (Off Ed). 1990 Dec 15;25(12):123, 126, 129-30. doi: 10.1080/21548331.1990.11704052.
Mitochondrial creatine kinase in human health and disease.
Schlattner U, Tokarska-Schlattner M, Wallimann T.
Biochim Biophys Acta. 2006 Feb;1762(2):164-80. doi: 10.1016/j.bbadis.2005.09.004. Epub 2005 Sep 27.
[Creatine kinase and its isozymes].
Takagi Y, Yasuhara T, Gomi K.
Rinsho Byori. 2001 Nov;Suppl 116:52-61.
Creatine kinase and its isoenzymes in neoplastic disease.
Tsung JS.
Crit Rev Clin Lab Sci. 1986;23(1):65-75. doi: 10.3109/10408368609165795.
Creating ATP via creatine kinase B for NLRP3 activation.
Toller-Kawahisa JE, O'Neill LAJ.
Nat Immunol. 2022 May;23(5):653-655. doi: 10.1038/s41590-022-01191-5.
[Creatine kinase (CK)].
Shoji S.
Nihon Rinsho. 1995 May;53(5):1136-40.
